SK-PHARMA REVITALIZING THE PHARMACEUTICAL SPHERE

    

Our Goals

SK-Pharma is a global pharmaceutical company focusing on early genericism of valuable medicinal products worldwide. Our mission is to improve wellbeing by allowing accessible medicines to all patients in needs. At SK-Pharma our core business is to launch complex and non-infringing generic medicines in the markets of interest, such as Israel & Palestinian Authority, CIS, Balkans and Latin America. Additionally, our company provide access to a Patient Support Program for rare and unique products as well as providing products that are difficult to obtain to thousands of patients globally. Our team also works closely with worldwide drug shortages using our special capabilities to foresee shortages. Utilizing our unique smart machine and data management tool ‘GDS’, enables our team at SK-Pharma the ability, to apply cutting edge technologies, to offer smart and timely solutions for drug shortages and supply issues. Our group is divided into different departments; elite business development, business intelligence, IP & litigation, data science and creative regulatory affairs. Together our teams synergistically engage to support our mission of leading the industry by providing unique, practical and realistic solutions.

   

Our Focused Agenda

To be a leading “First-to-Market” generic player. We aim to achieve this through; strategic alliances, product development, licensing and manufacturing of specialty pharmaceuticals. Our company goal is to achieve 80% of our developments as “First-to-Market” products. We are striving to improve and secure our product portfolio and market of operations based on ‘Blue Ocean Strategy’, where low competition and high growth is expected. Our laser focus on early launch opportunities is our leading catalyst for success within our stable business environment. Our innovative technological advances allow us to be “one step ahead” of our competitors allowing for our fast and efficient business.

   

Join our mission

We export international pharmaceutical products to pharmacies, wholesalers 
and manufacturers in over 60 countries, such as EU, USA, Russia and Latin 
America. We acquire our medicines exclusively from selected suppliers and 
operate under strict compliance with specific regulatory bodies, such as the 
Israel Ministry of Health. Contact us for more information.

  

Meet our CEO

Shlomo is the Founder and CEO of SK-Pharma Group, a global pharmaceutical company that manufactures, sells, and markets generic, specialty pharma, hybrid generics and biosimilar pharmaceutical products in over 15 countries.

Articles by our CEO

Apocalyptic Generic Prophecy

Articles by our CEO

Beyond the Pill

Articles by our CEO

Pharmaceutical company, In the Line of Fire

   

Worldwide offices

Our company has representative offices in 7 countries and as well as strategic partners in more than 50 countries across the globe.

Our company’s growth is driven by global generics.

up icon